Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity

Science

Volumn 347, Issue 6219, 2015, Pages 269-273

  Nice, Timothy J ^a   Baldridge, Megan T ^a   McCune, Broc T ^a   Norman, Jason M ^a   Lazear, Helen M ^a   Artyomov, Maxim ^a   Diamond, Michael S ^a   Virgin, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CAPSID PROTEIN; INTERFERON; LAMBDA INTERFERON; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; UNCLASSIFIED DRUG; CYTOKINE; INTERFERON-LAMBDA PROTEIN, MOUSE;

DISEASE TRANSMISSION; DISEASE TREATMENT; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNITY; PROTEIN; RODENT; VIRAL DISEASE; VIRUS;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; NOROVIRUS INFECTION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RADIOSENSITIVITY; VIRAL GASTROENTERITIS; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CALICIVIRIDAE INFECTIONS; CELL CULTURE; FECES; GASTROENTERITIS; IMMUNOLOGY; METABOLISM; NOROVIRUS; PHYSIOLOGY; VIROLOGY; VIRUS SHEDDING;

MIRIDAE; MURINE NOROVIRUS; MUS; NOROVIRUS;

ADAPTIVE IMMUNITY; ANIMALS; CALICIVIRIDAE INFECTIONS; CAPSID PROTEINS; CELLS, CULTURED; CYTOKINES; FECES; GASTROENTERITIS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-BETA; MICE; MICE, INBRED C57BL; NOROVIRUS; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 84922480732     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1258100     Document Type: Article

References (30)

1. S. M. Karst, C. E. Wobus, I. G. Goodfellow, K. Y. Green, H. W. Virgin, Cell Host Microbe 15, 668-680 (2014).
2. R. I. Glass, U. D. Parashar, M. K. Estes, N. Engl. J. Med. 361, 1776-1785 (2009).
3. G. Phillips, C. C. Tam, L. C. Rodrigues, B. Lopman, Epidemiol. Infect. 138, 1454-1458 (2010).
4. M. Saito et al., Clin. Infect. Dis. 58, 483-491 (2014).
5. J. Ayukekbong et al., J. Med. Virol. 83, 2135-2142 (2011).
6. D. S. Cheon et al., Foodborne Pathog. Dis. 7, 1427-1430 (2010).
7. F. H. Sukhrie, J. J. Siebenga, M. F. Beersma, M. Koopmans, J. Clin. Microbiol. 48, 4303-4305 (2010).
8. F. H. Sukhrie et al., Clin. Infect. Dis. 54, 931-937 (2012).
9. B. Lopman, K. Simmons, M. Gambhir, J. Vinjé, U. Parashar, Am. J. Epidemiol. 179, 507-512 (2014).
10. V. T. Tomov et al., J. Virol. 87, 7015-7031 (2013).
11. T. J. Nice, D. W. Strong, B. T. McCune, C. S. Pohl, H. W. Virgin, J. Virol. 87, 327-334 (2013).
12. S. M. Karst, C. E. Wobus, M. Lay, J. Davidson, H. W. Virgin IV, Science 299, 1575-1578 (2003).
13. C. E. Wobus et al., PLOS Biol. 2, e432 (2004).
14. K. O. Chang, D. W. George, J. Virol. 81, 12111-12118 (2007).
15. K. O. Chang, S. V. Sosnovtsev, G. Belliot, A. D. King, K. Y. Green, Virology 353, 463-473 (2006).
16. L. B. Thackray et al., J. Virol. 86, 13515-13523 (2012).
17. S. A. McCartney et al., PLOS Pathog. 4, e1000108 (2008).
18. S. Hwang et al., Cell Host Microbe 11, 397-409 (2012).
19. T. Taniguchi, A. Takaoka, Curr. Opin. Immunol. 14, 111-116 (2002).
20. A. J. Sadler, B. R. Williams, Nat. Rev. Immunol. 8, 559-568 (2008).
21. J. Pott et al., Proc. Natl. Acad. Sci. U.S.A. 108, 7944-7949 (2011).
22. D. W. Strong, L. B. Thackray, T. J. Smith, H. W. Virgin, J. Virol. 86, 2950-2958 (2012).
23. B. N. Borin et al., Proteins 82, 1200-1209 (2014).
24. M. K. Jones et al., Science 346, 755-759 (2014).
25. N. Ank et al., J. Immunol. 180, 2474-2485 (2008).
26. M. Mordstein et al., J. Virol. 84, 5670-5677 (2010).
27. C. Sommereyns, S. Paul, P. Staeheli, T. Michiels, PLOS Pathog. 4, e1000017 (2008).
28. G. Liu, S. M. Kahan, Y. Jia, S. M. Karst, J. Virol. 83, 6963-6968 (2009).
29. K. A. Chachu, A. D. LoBue, D. W. Strong, R. S. Baric, H. W. Virgin, PLOS Pathog. 4, e1000236 (2008).
30. B. Zhang et al., Science 346, 861-865 (2014).